Purpose

This study investigates whether an experimental medication is effective in slowing the progression of preclinical Alzheimer’s Disease in individuals with mild symptoms with or without a family history of AD.

Category

IRB Number
20200461HU
NCT Number
-
Sponsor
-



Study Contact

Principal Investigator
Arash Salardini

Floyd Jones
210-450-3158
jonesfa@uthscsa.edu



Eligibility

Eligible Ages
Between 55 and 80
Eligible Genders
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

    Participants must have a study partner who is willing to provide information about the individual’s daily activities. ???????

Exclusion Criteria

    Recent history of stroke, seizures, or major psychiatric illness. Inability to complete MRI scans.


Study Design

Arm Groups